Sphingosine kinase 1 as an anticancer therapeutic target
Ying Gao,1,* Fei Gao,2,* Kan Chen,3,* Mei-li Tian,1 Dong-li Zhao1 1Department of Radiotherapy Oncology, First Affiliated Hospital of Xi’an Jiaotong University, 2Department of Neurology, First Affiliated Hospital of Xi’an Medical University, Xi’an, 3School of Life Scien...
Main Authors: | Gao Y, Gao F, Chen K, Tian ML, Zhao DL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-06-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/sphingosine-kinase-1-as-an-anticancer-therapeutic-target-peer-reviewed-article-DDDT |
Similar Items
-
The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target
by: Xianwang Wang PhD, et al.
Published: (2020-12-01) -
Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy
by: Preeti Gupta, et al.
Published: (2019-10-01) -
Discovery and characterisation of novel anticancer compounds acting on sphingosine kinase
by: Lim, Keng Gat
Published: (2011) -
Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy
by: Preeti Gupta, et al.
Published: (2021-04-01) -
Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
by: Yonghua Bao, et al.
Published: (2017-10-01)